|
| | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid Basic information |
| Product Name: | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | | Synonyms: | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid;Cefdinir Thiazine Analog;Cefdinir Impurity 10;Cefdinir impurity 5/Cefdinir CP Impurity E/(Z)-2-((R)-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)(carboxy)methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid;2H-1,3-Thiazine-2-acetic acid, α-[[(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-4-carboxy-5-ethylidene-5,6-dihydro-, [R-[R*,R*-(Z,Z)]]- (9CI);Cefdinir Impurity E(CP),Cefdinir Thiazine Analog;Cefdinir Impurity 52;Cefdinir Impurity H(Cefdinir CP Impurity E) | | CAS: | 178422-39-4 | | MF: | C14H15N5O6S2 | | MW: | 413.42 | | EINECS: | | | Product Categories: | | | Mol File: | 178422-39-4.mol |  |
| | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid Chemical Properties |
| density | 1.81±0.1 g/cm3(Predicted) | | pka | -2.91±0.40(Predicted) |
| | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid Usage And Synthesis |
| Uses | Cefdinir Thiazine Analog is hydrolytic degradation product of Cefdinir (C242670). |
| | (R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid Preparation Products And Raw materials |
|
